Evidence map›Paper›PMID 35284879›Full record

ArticleCurrent research in parasitology & vector-borne diseases2021

Biolarviciding for malaria vector control: Acceptance and associated factors in southern Tanzania.

Athuman Yusuph Matindo, Secilia Ngʼweshemi Kapalata, Leonard Kamanga Katalambula, Eugene Benjamin Meshi, David Zadock Munisi

Abstract read
In one paragraph

Article in Current research in parasitology & vector-borne diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Current research in parasitology & vector-borne diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Athuman Yusuph MatindoDepartment of Health, Liwale District Council, Liwale, Tanzania.
Secilia Ngʼweshemi KapalataDepartment of Community Medicine, School of Medicine and Dentistry, University of Dodoma, Dodoma, Tanzania.
Leonard Kamanga KatalambulaDepartment of Public Health, School of Nursing and Public Health, University of Dodoma, Dodoma, Tanzania.
Eugene Benjamin MeshiDepartment of Community Medicine, School of Medicine and Dentistry, University of Dodoma, Dodoma, Tanzania.
David Zadock MunisiDepartment of Microbiology and Parasitology, School of Medicine and Dentistry, University of Dodoma, Dodoma, Tanzania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the struggle towards malaria elimination, the government of Tanzania scaled up nationwide biolarviciding to supplement existing vector control measures. As with any community-based intervention, success of biolarviciding depends on acceptability to the community. This study sought to ascertain acceptance of biolarviciding among communities in southern Tanzania. A mixed-method study involved administration of questionnaires to 400 community members, with 32 key informant interviews and five in-depth interviews also held in selected councils of southern Tanzania. A multistage sampling method was employed in selecting community members, with purposive sampling used in selecting key informant and in-depth interviewees. The study found high community acceptance (80.3%) despite very low (19.3%) knowledge on biolarviciding. Community perception that biolarvicide is effective in reducing malaria infection was found to be a significant predictor of community acceptance to biolarviciding: those who perceived biolarvicide as effective in reducing malaria were five times more likely to accept biolarviciding compared to those with a negative perception (odds ratio = 4.67, 95% CI: 1.89-11.50,

Indexed as

BiolarvicidingCommunity acceptanceMalariaMosquitoesSouthern Tanzania

Identifiers

PMID35284879
PMCPMC8906130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.